All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Women receive a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men, according to a gender-based sub-analysis of the MADIT-CRT trial data published in the current issue of the Journal of American College of Cardiology (Washington). (Medical Device Daily)